Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCP | P55072 | 1/20 | 0.75 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.60 |
| ▸ | MITF | O75030 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 5/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10625119 | 0.95 | VCP (0.81) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| Iodobenzene SCHEMBL27743145 | 0.90 | VCP (0.64) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL9124703 | 0.90 | HSP90AA1 (0.69) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL13077510 | 0.88 | APP (0.69) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL13077427 | 0.88 | VCP (0.71) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL24808421 | 0.86 | VCP (0.74) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL9069649 | 0.86 | VCP (0.59) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL13284136 | 0.86 | VCP (0.69) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL15827958 | 0.86 | VCP (1.00) | VCPHSP90AA1NPSR1ALDH1A1MAPT | |
| SCHEMBL9194059 | 0.86 | VCP (0.69) | VCPHSP90AA1NPSR1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024044232-A1 | COMPOSITIONS AND METHODS FOR SELECTIVE LABELING OF N-ALKYLATED IMIDAZOLE CONTAINING COMPOUNDS AND PEPTIDES | EMORY UNIVERSITY (US) | 2024-02-29 | — | — | WO | claimed |
| EP-0476658-B1 | 1-Phenyl-3-phenyl-2-propyne-1-ones | MERRELL DOW PHARMA (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0476658-A1 | 1-Phenyl-3-phenyl-2-propyne-1-ones | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-03-25 | — | — | EP | claimed |
| US-4070333-A | AROMATIZATION CATALYST, ADDITION POLYMERIZATION | HERCULES INCORPORATED (US) | 1978-01-24 | — | — | US | claimed |
| US-20250186408-A1 | TREATMENT OF PHARMACORESISTANT EPILEPSY | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2025-06-12 | — | — | US | disclosed |
| US-20250059229-A1 | Compositions and Methods for Selective Labeling of Secondary Amines | UNIV EMORY (US) | 2025-02-20 | — | — | US | disclosed |
| EP-4333819-A1 | TREATMENT OF PHARMACORESISTANT EPILEPSY | Katholieke Universiteit Leuven (BE) | 2024-03-13 | — | — | EP | disclosed |
| WO-2024044232-A1 | COMPOSITIONS AND METHODS FOR SELECTIVE LABELING OF N-ALKYLATED IMIDAZOLE CONTAINING COMPOUNDS AND PEPTIDES | EMORY UNIVERSITY (US) | 2024-02-29 | — | — | WO | disclosed |
| CN-115197046-B | Halogenation method of unsaturated hydrocarbon | 华南理工大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-115197108-B | Preparation method of gamma-ketosulfone compound | 南华大学 | 2023-11-28 | — | — | CN | disclosed |
| CN-113636972-B | Polysubstituted benzene compound and synthesis method thereof | 华东师范大学 | 2023-11-10 | — | — | CN | disclosed |
| CN-115073401-B | 2,3 '-bisfuran compound, 2,3' -oligomeric furan compound, and preparation methods and applications thereof | 华南理工大学 | 2023-07-14 | — | — | CN | disclosed |
| EP-0000385-A1 | Thermosetting compositions based on polyarylacetylenes and substituted polyphenylene oxides and resins obtained by curing them | HERCULES INCORPORATED (US) | 1979-01-24 | — | — | EP | disclosed |
| US-4097460-A | DIPHENYLACETYLENE, DIPHENYLBUTADIYNE, MOLDING MATERIALS FOR HIGH TEMPERATURE APPLICATIONS | HERCULES INCORPORATED (US) | 1978-06-27 | — | — | US | disclosed |
| US-4070333-A | AROMATIZATION CATALYST, ADDITION POLYMERIZATION | HERCULES INCORPORATED (US) | 1978-01-24 | — | — | US | disclosed |
| US-4026859-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026860-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026861-A | AROMATIZATION CATALYST | HERCULES INCORPORATED (US) | 1977-05-31 | — | — | US | disclosed |
| US-3993711-A | THERMOSETTING RESINS; COUPLING AGENTS; CARBOXYLATED PREPOLYMER | HERCULES INCORPORATED (US) | 1976-11-23 | — | — | US | disclosed |
| US-3931093-A | CURING | HERCULES INCORPORATED (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186408-A1 | TREATMENT OF PHARMACORESISTANT EPILEPSY | CNR1, CNR2, CYP2J2 | VCP 4323/4885HSP90AA1 3775/4885NPSR1 233/4885 |
| US-20250059229-A1 | Compositions and Methods for Selective Labeling of Secondary Amines | RNMT, DOT1L, ADAR | VCP 4807/4885HSP90AA1 3540/4885NPSR1 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.